Tendency to Suicide as a Sequel of Computer Vision Syndrome

March 30, 2023 updated by: Prof. Mohammed Iqbal, Sohag University

Prevalence and Associated Risk Factors of Tendency to Suicide as a Sequel of Computer Vision Syndrome Among Medical Students in Egypt

CVS-F4 questionnaire will be used as an instrument to survey prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

CVS-F4 (30 questions) will be an online survey via the SurveyMonkey Company. We will collect the responses and analyze the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. The questionnaire includes questions regarding potential ocular, extra-ocular, musclo-skeletal and neuro-psychatric complains caused by CVS. CVS-F4 questionnaire will be used as an instrument to survey prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents Complete statistical analysis of the survey data will be done using univariate and multivariate logistic and linear regression analysis.

Study Type

Observational

Enrollment (Actual)

3512

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Sohag, Egypt, 82425
        • Faculty of medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

medical students or staff who are using screens in their medical studies or personal lives and how these screens affect their medical studies and the effect of mandated medical computer use if present on their screen-behaviour, tendency to suicide and associated risk factor

Description

Inclusion Criteria:

  • university students
  • university staff members

Exclusion Criteria:

  • hysteria
  • ocular surgery
  • amblyopia
  • anisometropia
  • strabismus
  • systemic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tendency to suicide
Time Frame: 3 months
The participants will respond to Computer Vision Syndrome (CVS-F4) questionnaire and the number and percentage of participants suffering from tendency to suicide will be recorded
3 months
Depression
Time Frame: 3 months
The participants will respond to Computer Vision Syndrome (CVS-F4) questionnaire and the number and percentages of participants suffering from tendency to suicide and depression will be recorded. A correlation between depression and tendency to suicide will be measured as P value less than 0.05 will be significant
3 months
Screen-time
Time Frame: 3 months
The total daily average screen-hours will be measured using mean and standard deviation
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Investigators

  • Principal Investigator: Mohammed Iqbal Iqbal, MD, PhD, Professor of Ophthalmology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 30, 2022

Primary Completion (Actual)

February 20, 2023

Study Completion (Actual)

March 30, 2023

Study Registration Dates

First Submitted

October 9, 2022

First Submitted That Met QC Criteria

January 16, 2023

First Posted (Actual)

January 26, 2023

Study Record Updates

Last Update Posted (Actual)

March 31, 2023

Last Update Submitted That Met QC Criteria

March 30, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med-22-10-25

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The study data will available at the principal investigator for other researchers upon reasonable request after publication of the study

IPD Sharing Time Frame

12 months

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Computer Vision Syndrome

Clinical Trials on Suicide GROUP

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe